These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16081487)

  • 1. Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats.
    Jackson DN; Milne KJ; Noble EG; Shoemaker JK
    J Physiol; 2005 Oct; 568(Pt 2):573-81. PubMed ID: 16081487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats.
    Jackson DN; Milne KJ; Noble EG; Shoemaker JK
    J Physiol; 2005 Jan; 562(Pt 1):285-94. PubMed ID: 15513938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen modulates the contribution of neuropeptide Y to baseline hindlimb blood flow control in female Sprague-Dawley rats.
    Jackson DN; Ellis CG; Shoemaker JK
    Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1351-7. PubMed ID: 20219870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-diabetes augments neuropeptide Y1- and α1-receptor control of basal hindlimb vascular tone in young ZDF rats.
    Novielli NM; Al-Khazraji BK; Medeiros PJ; Goldman D; Jackson DN
    PLoS One; 2012; 7(10):e46659. PubMed ID: 23071607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
    El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
    Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y(2) receptor evidenced by BIIE0246.
    Malmström RE; Lundberg JO; Weitzberg E
    Eur J Pharmacol; 2002 Mar; 439(1-3):113-9. PubMed ID: 11937100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release.
    King PJ; Williams G; Doods H; Widdowson PS
    Eur J Pharmacol; 2000 May; 396(1):R1-3. PubMed ID: 10822055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y1- and alpha1-receptor control of basal hindlimb vascular tone.
    Jackson DN; Noble EG; Shoemaker JK
    Am J Physiol Regul Integr Comp Physiol; 2004 Jul; 287(1):R228-33. PubMed ID: 15044188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.
    Doods H; Gaida W; Wieland HA; Dollinger H; Schnorrenberg G; Esser F; Engel W; Eberlein W; Rudolf K
    Eur J Pharmacol; 1999 Nov; 384(2-3):R3-5. PubMed ID: 10611450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
    Tu B; Jiao Y; Herzog H; Nadler JV
    Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.
    Malmström RE
    Br J Pharmacol; 2001 Aug; 133(7):1073-80. PubMed ID: 11487518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.
    Dumont Y; Cadieux A; Doods H; Pheng LH; Abounader R; Hamel E; Jacques D; Regoli D; Quirion R
    Br J Pharmacol; 2000 Mar; 129(6):1075-88. PubMed ID: 10725255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
    Hyland NP; Sjöberg F; Tough IR; Herzog H; Cox HM
    Br J Pharmacol; 2003 Jun; 139(4):863-71. PubMed ID: 12813010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the neuropeptide Y Y(2) receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices.
    Weiser T; Wieland HA; Doods HN
    Eur J Pharmacol; 2000 Sep; 404(1-2):133-6. PubMed ID: 10980271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
    Chen SH; Cheung RT
    Neuroscience; 2003; 116(1):119-26. PubMed ID: 12535945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of peripheral neuropeptide Y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin.
    Lin Q; Zou X; Ren Y; Wang J; Fang L; Willis WD
    Neuroscience; 2004; 123(2):337-47. PubMed ID: 14698742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
    Ekelund U; Erlinge D
    Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y and neurovascular control in skeletal muscle and skin.
    Hodges GJ; Jackson DN; Mattar L; Johnson JM; Shoemaker JK
    Am J Physiol Regul Integr Comp Physiol; 2009 Sep; 297(3):R546-55. PubMed ID: 19571208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in the sympathoexcitatory response to insulin in obese rats: role of neuropeptide Y.
    Shi Z; Cassaglia PA; Pelletier NE; Brooks VL
    J Physiol; 2019 Mar; 597(6):1757-1775. PubMed ID: 30628058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.